UBS keeps JPY 3,400.00 target for Terumo stock

Published on 10/15/2026 at 22:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

UBS keeps a JPY 3,400.00 target for Terumo on October 14, 2026. Terumo stock costs EUR 13.13 on October 15, 2026 at 10:08 p.m. CEST.

Analyst view and valuation

On October 14, 2026, UBS maintained a Buy rating and a JPY 3,400.00 target for Terumo.
Terumo closed at JPY 2,254.50 in Tokyo on October 14, 2026.
Terumo stock costs EUR 13.13 at Lang & Schwarz on October 15, 2026 at 10:08 p.m. CEST.
Terumo trades at a P/E ratio of 20.65 with a JPY 3.4 trillion market capitalization.

Terumo, JP3546800008, Illustration mit AI erstellt.

UBS maintained its Buy rating and JPY 3,400.00 price target for Terumo on October 14, 2026, putting the target 47.67 percent above the Tokyo share price of JPY 2,302.50. The target update gives investors a fresh benchmark while the German euro quotation remains the practical reference for local trading. At Lang & Schwarz, Terumo was trading at EUR 13.13 on October 15, 2026 at 10:08 p.m. CEST.

Target leaves room above Tokyo

The UBS target compares with Terumo's Tokyo price of JPY 2,302.50 at the October 15, 2026 close. The share had reached JPY 2,689.00 over the previous 52 weeks and had fallen to JPY 1,900.00, leaving the current Tokyo price 14.37 percent below the yearly high and 21.18 percent above the yearly low.

Terumo's Tokyo listing closed at JPY 2,254.50 on October 14, 2026, according to Global Banking and Finance Review. That close was 3.18 percent below the prior Tokyo session, while the October 15 finance quote placed the share at JPY 2,302.50.

Valuation and upcoming dates

Terumo's market capitalization was JPY 3.4 trillion and its trailing P/E ratio was 20.65 on October 15, 2026. The company identifies its listing as the Prime Market of the Tokyo Stock Exchange on its Terumo investor page. A dated UBS target therefore provides the clearest valuation marker in the current picture.

Comparison with peers

Terumo (Tokyo Stock Exchange, JPY): P/E 20.65, market capitalization JPY 3.4 trillion
Edwards Lifesciences (NYSE, USD): daily change plus 1.89 percent, P/E 50.62, market capitalization USD 50.8 billion
Boston Scientific (NYSE, USD): daily change plus 2.69 percent, P/E 17.95, market capitalization USD 64.0 billion

What the target means

The UBS target is a valuation marker rather than a forecast from this article. Its 47.67 percent distance from the Tokyo price is the largest quantified signal in the current Terumo picture, while the 20.65 P/E ratio places the company between the two selected US medical-device peers.

Terumo stock after hours

The euro quotation places Terumo at EUR 13.13 in after-hours trading at Lang & Schwarz on October 15, 2026 at 10:08 p.m. CEST. The next market reference for German readers is the Tokyo listing, where the October 15 session closed at JPY 2,302.50.

The further course of trading is shown by the continuously updated real-time quote of Terumo stock.